Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registry

Acta Oncologica

Volumn 52, Issue 2, 2013, Pages 249-258

  Husson, Olga ^a,b   Haak, Harm R ^c   Buffart, Laurien M ^d   Nieuwlaat, Willy Anne ^e   Oranje, Wilma A ^f   Mols, Floortje ^a,b   Kuijpens, Johannes L ^g   Coebergh, Jan Willem ^b,h   Van De Poll Franse, Lonneke V ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Elisabeth Hospital Tilburg   (Netherlands)

^f CPRLab   (Netherlands)

^g VGZ Health Insurance Company   (Netherlands)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVOR; CHILL; CLINICAL FEATURE; COGNITION; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FOLLOW UP; HEALTH SURVEY; HOT FLUSH; HUMAN; LEG CRAMP; LEG PAIN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEUROMUSCULAR DISEASE; PATIENT CARE; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEX RATIO; SOCIAL STATUS; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; ARTICLE; ASSOCIATION; EMOTION; QUALITY OF LIFE INDEX; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SYMPTOM; THYROID CANCER;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; SURVIVORS; THYROID NEOPLASMS;

EID: 84872563472     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.741326     Document Type: Conference Paper

References (25)

1. Dutch cancer fi gures. [cited 2012 Sep 24]. Available from: http://www.cijfersoverkanker.nl
2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7.
3. Davies L, Welch HG. Thyroid cancer survival in the United States: Observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg 2010; 136: 440-4.
4. Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl 5): v214-9.
5. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am JMed 1994; 97: 418-28.
6. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Health-related quality of life among thyroid cancer survivors: Asystematic review. Clin Endocrinol (Oxf) 2011; 75: 544-54.
7. Husson O, Haak HR, Mols F, Nieuwenhuijzen GAP, Nieuwlaat WA, Reemst PH, et al. Development of adisease-specifi chealth-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol Epub 2012 Sep 27.
8. Janssen-Heijnen MLG, Louwman WJ, Van de Poll-Franse LV, Coebergh JWW. Results of 50 years cancer registry in the South of the Netherlands: 1955-2004 (in Dutch). Eindhoven: Eindhoven Cancer Registry; 2005.
9. van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 2011; 47: 2188-94.
10. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: Anew method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003; 49: 156-63.
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: aquality-of-life instrument for use in international clinical trials in oncology. JNatl Cancer Inst 1993; 85: 365-76. van de P
12. oll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 2011; 47: 667-75.
13. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 2011; 29: 89-96.
14. Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL. Quality of life in patients undergoing thyroid surgery. JOtolaryngol 2006; 35: 209-15.
15. Almeida JP, Vartanian JG, Kowalski LP. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg 2009; 135: 342-6.
16. Brown RL, de Souza JA, Cohen EE. Thyroid cancer: Burden of illness and management of disease. J Cancer 2011; 2: 193-9.
17. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: Aclue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-72.
18. Eustatia-Rutten CF, Corssmit EP, Heemstra KA, Smit JW, Schoemaker RC, Romijn JA, et al. Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism. J Clin Endocrinol Metab 2008; 93: 2835-41.
19. Utiger RD. Subclinical hyperthyroidism-just alow serum thyrotropin concentration, or something more? NEngl JMed 1994; 331: 1302-3.
20. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 2001; 358: 861-5.
21. Kuijpens JL, Janssen-Heijnen ML, Lemmens VE, Haak HR, HeiJ Ckmann AC, Coebergh JW. Comorbidity in newly diagnosed thyroid cancer patients: Apopulation-based study on prevalence and the impact on treatment and survival. Clin Endocrinol (Oxf) 2006; 64: 450-5.
22. Hirsch D, Ginat M, Levy S, Benbassat C, Weinstein R, Tsvetov G, et al. Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid 2009; 19: 459-65.
23. Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profi les and quality of life of 518 survivors of thyroid cancer. Head Neck 2003; 25: 349-56.
24. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010; 22: 395-404.
25. Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, et al. The impact of thyroid cancer and postsurgical radioactive iodine treatment on the lives of thyroid cancer survivors: Aqualitative study. PLoS One 2009; 4: e4191.